TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
890
|
2,751
|
725 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
37
|
2,046
|
513 |
| EBITDA |
190
|
2,059
|
513 |
| Total assets |
3,358
|
3,334
|
1,073 |
| Current assets |
2,759
|
2,581
|
1,073 |
| Current liabilities |
804
|
809
|
311 |
| Equity capital |
2,383
|
2,355
|
740 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
71.0%
|
70.6%
|
69.0% |
| Turnover per employee |
890
|
2,751
|
725 |
| Profit as a percentage of turnover |
4.2%
|
74.4%
|
70.8% |
| Return on assets (ROA) |
1.1%
|
61.4%
|
47.8% |
| Current ratio |
343.2%
|
319.0%
|
345.0% |
| Return on equity (ROE) |
1.6%
|
86.9%
|
69.3% |
| Change turnover |
-1,861
|
2,026
|
598 |
| Change turnover % |
-68%
|
279%
|
471% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.